Central Nervous System(CNS) Efficacy of Dacomitinib
NCT04675008
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Non Small Cell Lung Cancer
Brain Metastases
Interventions
DRUG:
Dacomitinib
Sponsor
Samsung Medical Center